IN191819B - - Google Patents

Info

Publication number
IN191819B
IN191819B IN778DE2001A IN191819B IN 191819 B IN191819 B IN 191819B IN 778DE2001 A IN778DE2001 A IN 778DE2001A IN 191819 B IN191819 B IN 191819B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Mohammad Salman
Ashwani Kumar Verma
Rita Katoch
Ashok Rattan
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN778DE2001 priority Critical patent/IN191819B/en
Priority to PCT/IB2002/002662 priority patent/WO2003008391A1/en
Priority to EP02743488A priority patent/EP1412337A4/de
Publication of IN191819B publication Critical patent/IN191819B/en
Priority to US10/483,906 priority patent/US20040242896A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN778DE2001 2001-07-19 2001-07-19 IN191819B (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IN778DE2001 IN191819B (de) 2001-07-19 2001-07-19
PCT/IB2002/002662 WO2003008391A1 (en) 2001-07-19 2002-07-08 Azole compounds as anti-fungal agents
EP02743488A EP1412337A4 (de) 2001-07-19 2002-07-08 Azolverbindungen als antipilzmittel
US10/483,906 US20040242896A1 (en) 2001-07-19 2004-06-28 Azole compounds as anti-fungal agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN778DE2001 IN191819B (de) 2001-07-19 2001-07-19

Publications (1)

Publication Number Publication Date
IN191819B true IN191819B (de) 2004-01-03

Family

ID=33397662

Family Applications (1)

Application Number Title Priority Date Filing Date
IN778DE2001 IN191819B (de) 2001-07-19 2001-07-19

Country Status (4)

Country Link
US (1) US20040242896A1 (de)
EP (1) EP1412337A4 (de)
IN (1) IN191819B (de)
WO (1) WO2003008391A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2013015434A (es) 2011-06-22 2014-10-14 Vyome Biosciences Pvt Ltd Profarmacos antifungicos y antibacterianos a base de conjugado.
CA2914583C (en) 2013-06-04 2019-06-18 Vyome Biosciences Pvt. Ltd. Coated particles and compositions comprising same
CN106163526B (zh) 2014-01-29 2021-07-23 维奥姆治疗有限公司 抗性痤疮的治疗

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310724A (en) * 1990-02-09 1994-05-10 Fmc Corporation Herbicidal substituted phenyl-1,2,4-triazol-5(1H)-thiones
TW218017B (de) * 1992-04-28 1993-12-21 Takeda Pharm Industry Co Ltd
CA2134417A1 (en) * 1993-12-22 1995-06-23 Katsumi Itoh Optically active azole derivatives, their production and use
CA2150533A1 (en) * 1994-05-31 1995-12-01 Katsumi Itoh Production of optically active triazole compounds and their intermediates
TW318841B (de) * 1995-02-17 1997-11-01 Takeda Pharm Industry Co Ltd
DE19620407A1 (de) * 1996-05-21 1997-11-27 Bayer Ag Thiocyano-triazolyl-Derivate
CA2433259A1 (en) * 2000-12-26 2002-07-04 Ranbaxy Laboratories Limited Azole compounds as anti-fungals agents

Also Published As

Publication number Publication date
WO2003008391A1 (en) 2003-01-30
US20040242896A1 (en) 2004-12-02
EP1412337A4 (de) 2004-12-22
EP1412337A1 (de) 2004-04-28

Similar Documents

Publication Publication Date Title
BE2022C531I2 (de)
BE2022C502I2 (de)
BE2022C547I2 (de)
BE2017C057I2 (de)
BE2017C051I2 (de)
BE2017C032I2 (de)
BE2016C051I2 (de)
BE2015C046I2 (de)
BE2014C052I2 (de)
BE2014C036I2 (de)
BE2014C026I2 (de)
BE2014C004I2 (de)
BE2014C006I2 (de)
BE2017C050I2 (de)
JP2001224406A5 (de)
JP2002072964A5 (de)
BE2014C008I2 (de)
BRPI0204884B1 (de)
CH1379220H1 (de)
BE2016C021I2 (de)
BE2017C059I2 (de)
JP2002082794A5 (de)
BRPI0101486B8 (de)
BE2012C051I2 (de)
BRPI0210463A2 (de)